Boost Biopharma, Inc. is a U.S.-based, clinical-stage biopharmaceutical company developing high-performance proteins at the speed of mRNA. The company is supported by CEPI, NIH/NIAID, and BARDA relating to preclinical and clinical development of its vaccines and monoclonal antibody therapeutics.